IOL Chemicals and Pharmaceuticals Limited (IOLCP) – Financial and Strategic SWOT Analysis Review
Summary
IOL Chemicals and Pharmaceuticals Limited (IOLCP) is an India-based manufacturer and supplier of organic chemicals. The company manufactures and supplies chemicals and pharmaceutical products with a wide portfolio of chemicals and bulk drugs. The company operates its business in two reportable segments, namely, the Chemical and Pharmaceuticals. The products of the Chemical business segment include Acetic Acid, Ethyl Acetate and Acetic Anhydride, and the products for the Pharmaceuticals segment is Ibuprofen. The company manufactures raw materials for numerous other drugs including catalysts, active reactants, and solvents. The company has two manufacturing units. Geographically, the company serves to the markets of Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt and many other countries. IOLCP is headquartered in Punjab, India.
IOL Chemicals and Pharmaceuticals Limited Key Recent Developments
May 30, 2012: IOL Reports Revenue Of INR4.7 Billion In Fiscal 2012
Feb 11, 2012: IOL Reports Revenue Of INR1.3 Billion In Q3 Fiscal 2012
Nov 14, 2011: IOL Reports Net Profit Of INR13.73m In Q2 Fiscal 2012
Aug 12, 2011: IOL Reports Net Profit Of INR9.74m In Q1 Fiscal 2012
Jul 11, 2011: IOL Announces Board Changes
This comprehensive SWOT profile of IOL Chemicals and Pharmaceuticals Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
Summary
IOL Chemicals and Pharmaceuticals Limited (IOLCP) is an India-based manufacturer and supplier of organic chemicals. The company manufactures and supplies chemicals and pharmaceutical products with a wide portfolio of chemicals and bulk drugs. The company operates its business in two reportable segments, namely, the Chemical and Pharmaceuticals. The products of the Chemical business segment include Acetic Acid, Ethyl Acetate and Acetic Anhydride, and the products for the Pharmaceuticals segment is Ibuprofen. The company manufactures raw materials for numerous other drugs including catalysts, active reactants, and solvents. The company has two manufacturing units. Geographically, the company serves to the markets of Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt and many other countries. IOLCP is headquartered in Punjab, India.
IOL Chemicals and Pharmaceuticals Limited Key Recent Developments
May 30, 2012: IOL Reports Revenue Of INR4.7 Billion In Fiscal 2012
Feb 11, 2012: IOL Reports Revenue Of INR1.3 Billion In Q3 Fiscal 2012
Nov 14, 2011: IOL Reports Net Profit Of INR13.73m In Q2 Fiscal 2012
Aug 12, 2011: IOL Reports Net Profit Of INR9.74m In Q1 Fiscal 2012
Jul 11, 2011: IOL Announces Board Changes
This comprehensive SWOT profile of IOL Chemicals and Pharmaceuticals Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
IOL Chemicals and Pharmaceuticals Limited - Key Facts
IOL Chemicals and Pharmaceuticals Limited - Key Employees
IOL Chemicals and Pharmaceuticals Limited - Key Employee Biographies
IOL Chemicals and Pharmaceuticals Limited - Major Products and Services
IOL Chemicals and Pharmaceuticals Limited - History
IOL Chemicals and Pharmaceuticals Limited - Company Statement
IOL Chemicals and Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
IOL Chemicals and Pharmaceuticals Limited - Key Manufacturing Facilities
SECTION 2 – COMPANY ANALYSIS
IOL Chemicals and Pharmaceuticals Limited - Business Description
IOL Chemicals and Pharmaceuticals Limited - Corporate Strategy
IOL Chemicals and Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
IOL Chemicals and Pharmaceuticals Limited - Strengths
Strength - Global Presence
Strength - Broad Range of Products
Strength - Strong liquidity
IOL Chemicals and Pharmaceuticals Limited - Weaknesses
Weakness - Higher Inventory
Weakness - Deteriorating Profitability Ratios
IOL Chemicals and Pharmaceuticals Limited - Opportunities
Opportunity - Growth in the Indian Economy
Opportunity - Market Consolidation
IOL Chemicals and Pharmaceuticals Limited - Threats
Threat - Cheaper Imports from Middle East
Threat - Growing Carbon Emissions and Tightening Regulation
Threat - Growing Competition
IOL Chemicals and Pharmaceuticals Limited - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S, LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Year, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Type, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
IOL Chemicals and Pharmaceuticals Limited, Recent Developments
May 30, 2012: IOL Reports Revenue Of INR4.7 Billion In Fiscal 2012
Feb 11, 2012: IOL Reports Revenue Of INR1.3 Billion In Q3 Fiscal 2012
Nov 14, 2011: IOL Reports Net Profit Of INR13.73m In Q2 Fiscal 2012
Aug 12, 2011: IOL Reports Net Profit Of INR9.74m In Q1 Fiscal 2012
Jul 11, 2011: IOL Announces Board Changes
May 21, 2011: IOL Reports Net Profit Of INR61.79m In Fiscal 2011
Feb 08, 2011: IOL Reports Net Profit Of INR14.7m For Q3 Fiscal 2011
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
IOL Chemicals and Pharmaceuticals Limited, Key Facts
IOL Chemicals and Pharmaceuticals Limited, Key Employees
IOL Chemicals and Pharmaceuticals Limited, Key Employee Biographies
IOL Chemicals and Pharmaceuticals Limited, Major Products and Services
IOL Chemicals and Pharmaceuticals Limited, History
IOL Chemicals and Pharmaceuticals Limited, Other Locations
IOL Chemicals and Pharmaceuticals Limited, Key Manufacturing Facilities
IOL Chemicals and Pharmaceuticals Limited, Key Competitors
IOL Chemicals and Pharmaceuticals Limited, Annual Ratios
IOL Chemicals and Pharmaceuticals Limited, Interim Ratios
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Year, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Type, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
IOL Chemicals and Pharmaceuticals Limited, Performance Chart (2008 - 2012)
IOL Chemicals and Pharmaceuticals Limited, Ratio Charts
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Year, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals by Type, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited - Key Facts
IOL Chemicals and Pharmaceuticals Limited - Key Employees
IOL Chemicals and Pharmaceuticals Limited - Key Employee Biographies
IOL Chemicals and Pharmaceuticals Limited - Major Products and Services
IOL Chemicals and Pharmaceuticals Limited - History
IOL Chemicals and Pharmaceuticals Limited - Company Statement
IOL Chemicals and Pharmaceuticals Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
IOL Chemicals and Pharmaceuticals Limited - Key Manufacturing Facilities
SECTION 2 – COMPANY ANALYSIS
IOL Chemicals and Pharmaceuticals Limited - Business Description
IOL Chemicals and Pharmaceuticals Limited - Corporate Strategy
IOL Chemicals and Pharmaceuticals Limited - SWOT Analysis
SWOT Analysis - Overview
IOL Chemicals and Pharmaceuticals Limited - Strengths
Strength - Global Presence
Strength - Broad Range of Products
Strength - Strong liquidity
IOL Chemicals and Pharmaceuticals Limited - Weaknesses
Weakness - Higher Inventory
Weakness - Deteriorating Profitability Ratios
IOL Chemicals and Pharmaceuticals Limited - Opportunities
Opportunity - Growth in the Indian Economy
Opportunity - Market Consolidation
IOL Chemicals and Pharmaceuticals Limited - Threats
Threat - Cheaper Imports from Middle East
Threat - Growing Carbon Emissions and Tightening Regulation
Threat - Growing Competition
IOL Chemicals and Pharmaceuticals Limited - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S, LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Year, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Type, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
IOL Chemicals and Pharmaceuticals Limited, Recent Developments
May 30, 2012: IOL Reports Revenue Of INR4.7 Billion In Fiscal 2012
Feb 11, 2012: IOL Reports Revenue Of INR1.3 Billion In Q3 Fiscal 2012
Nov 14, 2011: IOL Reports Net Profit Of INR13.73m In Q2 Fiscal 2012
Aug 12, 2011: IOL Reports Net Profit Of INR9.74m In Q1 Fiscal 2012
Jul 11, 2011: IOL Announces Board Changes
May 21, 2011: IOL Reports Net Profit Of INR61.79m In Fiscal 2011
Feb 08, 2011: IOL Reports Net Profit Of INR14.7m For Q3 Fiscal 2011
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
IOL Chemicals and Pharmaceuticals Limited, Key Facts
IOL Chemicals and Pharmaceuticals Limited, Key Employees
IOL Chemicals and Pharmaceuticals Limited, Key Employee Biographies
IOL Chemicals and Pharmaceuticals Limited, Major Products and Services
IOL Chemicals and Pharmaceuticals Limited, History
IOL Chemicals and Pharmaceuticals Limited, Other Locations
IOL Chemicals and Pharmaceuticals Limited, Key Manufacturing Facilities
IOL Chemicals and Pharmaceuticals Limited, Key Competitors
IOL Chemicals and Pharmaceuticals Limited, Annual Ratios
IOL Chemicals and Pharmaceuticals Limited, Interim Ratios
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Year, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Type, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
IOL Chemicals and Pharmaceuticals Limited, Performance Chart (2008 - 2012)
IOL Chemicals and Pharmaceuticals Limited, Ratio Charts
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals By Year, 2006 to YTD 2012
IOL Chemicals and Pharmaceuticals Limited, Petrochemicals, Deals by Type, 2006 to YTD 2012
